EDAP to Present at the Jefferies Global Healthcare Conference
EDAP TMS SA (Nasdaq: EDAP), a global leader in robotic energy-based therapies, has announced its participation in the upcoming Jefferies Global Healthcare Conference. CEO Ryan Rhodes will deliver a presentation and conduct one-on-one investor meetings during the conference, scheduled for June 3-5, 2025, in New York City.
Rhodes' presentation is set for Thursday, June 5th, from 4:20-4:50 PM ET. Investors can access both the live and archived webcast of the presentation through the company's website's Investor section or via the provided webcast link.
EDAP TMS SA (Nasdaq: EDAP), leader mondiale nelle terapie robotiche basate sull'energia, ha annunciato la sua partecipazione alla prossima Jefferies Global Healthcare Conference. L'Amministratore Delegato Ryan Rhodes terr脿 una presentazione e incontrer脿 investitori in sessioni individuali durante la conferenza, che si svolger脿 dal 3 al 5 giugno 2025 a New York City.
La presentazione di Rhodes 猫 prevista per gioved矛 5 giugno, dalle 16:20 alle 16:50 ET. Gli investitori potranno seguire la diretta o rivedere la registrazione della presentazione tramite la sezione Investor del sito web della societ脿 o attraverso il link per il webcast fornito.
EDAP TMS SA (Nasdaq: EDAP), l铆der mundial en terapias rob贸ticas basadas en energ铆a, ha anunciado su participaci贸n en la pr贸xima Jefferies Global Healthcare Conference. El CEO Ryan Rhodes realizar谩 una presentaci贸n y mantendr谩 reuniones individuales con inversores durante la conferencia, que se llevar谩 a cabo del 3 al 5 de junio de 2025 en la ciudad de Nueva York.
La presentaci贸n de Rhodes est谩 programada para el jueves 5 de junio, de 4:20 a 4:50 PM ET. Los inversores podr谩n acceder a la transmisi贸n en vivo y a la grabaci贸n a trav茅s de la secci贸n de inversores en el sitio web de la compa帽铆a o mediante el enlace proporcionado para el webcast.
EDAP TMS SA (雮橃姢雼�: EDAP), 鞐愲剤歆� 旮半皹 搿滊磭 旃橂 攵勳暭鞚� 旮�搿滊矊 毽崝臧� 雼り皜鞓る姅 Jefferies Global Healthcare Conference鞐� 彀胳棳頃滊嫟瓿� 氚滍憸頄堨姷雼堧嫟. CEO 霛检澊鞏� 搿滌電� 2025雲� 6鞗� 3鞚茧秬韯� 5鞚缄箤歆� 雺挫殨鞁滌棎靹� 鞐措Μ電� 旎嵓霟办姢 霃欖晥 氚滍憸毳� 頃橁碃 1:1 韴瀽鞛� 氙疙寘鞚� 歆勴枆頃� 鞓堨爼鞛呺媹雼�.
搿滌鞚� 氚滍憸電� 6鞗� 5鞚� 氇╈殧鞚� 鞓ろ泟 4鞁� 20攵勲秬韯� 4鞁� 50攵�(霃欕秬 響滌鞁�)旯岇 鞓堨爼霅橃柎 鞛堨姷雼堧嫟. 韴瀽鞛愲摛鞚� 須岇偓 鞗轨偓鞚错姼鞚� 韴瀽鞛� 靹轨厴鞚措倶 鞝滉车霅� 鞗轨簮鞀ろ姼 毵來伂毳� 韱淀暣 靸濎瓿� 氚� 雲鬼檾 氚╈啞鞚� 鞁滌箔頃� 靾� 鞛堨姷雼堧嫟.
EDAP TMS SA (Nasdaq : EDAP), leader mondial des th茅rapies robotiques bas茅es sur l'茅nergie, a annonc茅 sa participation 脿 la prochaine Jefferies Global Healthcare Conference. Le PDG Ryan Rhodes fera une pr茅sentation et tiendra des r茅unions individuelles avec des investisseurs lors de la conf茅rence, pr茅vue du 3 au 5 juin 2025 脿 New York.
La pr茅sentation de Rhodes est programm茅e pour le jeudi 5 juin, de 16h20 脿 16h50 (heure de l'Est). Les investisseurs pourront acc茅der au webcast en direct ainsi qu'脿 son enregistrement via la section Investisseurs du site internet de la soci茅t茅 ou via le lien webcast fourni.
EDAP TMS SA (Nasdaq: EDAP), ein weltweit f眉hrendes Unternehmen f眉r robotergest眉tzte, energiebasierte Therapien, hat seine Teilnahme an der bevorstehenden Jefferies Global Healthcare Conference angek眉ndigt. CEO Ryan Rhodes wird w盲hrend der Konferenz, die vom 3. bis 5. Juni 2025 in New York City stattfindet, eine Pr盲sentation halten und Einzelgespr盲che mit Investoren f眉hren.
Rhodes' Pr盲sentation ist f眉r Donnerstag, den 5. Juni, von 16:20 bis 16:50 Uhr ET geplant. Investoren k枚nnen die Live-脺bertragung sowie die Aufzeichnung der Pr盲sentation 眉ber den Investor-Bereich auf der Unternehmenswebsite oder den bereitgestellten Webcast-Link ansehen.
- None.
- None.
AUSTIN, Texas, May 27, 2025 -- EDAP TMS SA (Nasdaq: EDAP) (鈥渢he Company鈥�), the global leader in robotic energy-based therapies, today announced that Ryan Rhodes, Chief Executive Officer, is scheduled to deliver a presentation and host 1x1 investor meetings at the Jefferies Global Healthcare Conference, which is being held June 3-5, 2025, in New York City.聽
Presentation details:
| Date: | Thursday, June 5th |
| Time: | 4:20-4:50 PM ET |
| Webcast: |
The live and archived webcast of the presentation can be accessed in the Investors section of the Company鈥檚 website .
About EDAP TMS SA
A recognized leader in robotic energy-based therapies,聽EDAP TMS聽develops, manufactures, promotes and distributes worldwide minimally invasive medical devices for various conditions using ultrasound technology. By combining the latest technologies in imaging, robotics and precise non-invasive energy delivery,聽EDAP introduced the Focal聽One庐聽in聽Europe聽and in the聽U.S.聽as the leading prostate focal therapy controlled by urologists with the potential to expand to multiple indications beyond prostate cancer. For more information on the Company, please visit聽.
Company Contact
Blandine Confort
Investor Relations / Legal Affairs
EDAP TMS SA
+33 4 72 15 31 50
[email protected]
Investor Contact
John Fraunces
LifeSci Advisors, LLC
(917) 355-2395
FAQ
When is EDAP (EDAP) presenting at the Jefferies Global Healthcare Conference 2025?
How can I watch EDAP's (EDAP) presentation at the Jefferies Healthcare Conference?
Who will be representing EDAP (EDAP) at the Jefferies Global Healthcare Conference 2025?
What is EDAP's (EDAP) main business focus?
